Company / Profit Margin
Ernexa Therapeutics Inc. Profit Margin History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-7652.8%
FY2025
5-year range
-31864.7% / -1.1%
FY2021-FY2025
Trend
+76.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin returned to growth in FY2025 after 2 years of decline, reaching -7652.8%.
Based on SEC 10-K filings.
-7652.8% in FY2025 with a 10-year CAGR of -7633.4%.
Declined from -10.3% to -7652.8% over the past 5 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -7642.4pp
- 10-Year Change
- -7633.4pp
Key checks
Key Insights
- In FY2025, profit margin increased 76.0% year-over-year.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -7652.8% | +76.0% |
| FY2024 | -31864.7% | - |
| FY2023 | - | - |
| FY2020 | -10.3% | -831.5% |
| FY2019 | -1.1% | +78.1% |
| FY2018 | -5.1% | +61.4% |
| FY2017 | -13.1% | +55.5% |
| FY2016 | -29.5% | -52.6% |
| FY2015 | -19.3% | -335.9% |
| FY2014 | -4.4% | -7.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026